Daines calls for greater transparency on prescription-drug pricing
April 30, 2019
BILLINGS- More Americans struggle with paying for prescription drugs, and many times there’s someone in between the drug company and the consumer who negotiates the price. U.S. Sen. Steve Daines, R-Mont., said Monday he’s introduced a bill to create transparency around what that “middle man” is doing. That includes looking into the effects of company consolidation on drug pricing. As many companies merge, it creates less competition and allows for an increase in drug prices, according to Daines. In fact, three companies control a 73 percent share of the pharmacy benefit manager industry. One of the most well-known spikes is the 500 percent